It is a business services private limited company based in New Delhi, Delhi, India, established in 2017.
2017 | New Delhi, Delhi, India | ActiveHetas Pharmaceuticals Private Limited, a active private limited company, was established on 25 May 2017 in New Delhi, Delhi, India. Engaging in other services within the business services sector, it holds CIN: U74999DL2017PTC318145. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Tapan Sobhan Samantaray (Director), Hemanta Kumar Mishra (Director). Past directors included Sarbeswar Roul. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at K-1/114,First Floor, Cr Park, New Delhi, Delhi, 110019.
U74999DL2017PTC318145
318145
25 May 2017
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Hetas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tapan Sobhan Samantaray | Director | 25 May 2017 | Current |
| Hemanta Kumar Mishra | Director | 25 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hetas Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Hetas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hetas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hetas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hetas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Hetas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Tapan Sobhan Samantaray was appointed as a Director was appointed as a Director on 25 May 2017 & has been associated with this company since 8 years 6 months . was documented.
Progress on Hemanta Kumar Mishra was appointed as a Director was appointed as a Director on 25 May 2017 & has been associated with this company since 8 years 6 months . was documented.
Progress on Hetas Pharmaceuticals Private Limited was registered on 25 May 2017 with Roc Delhi & aged 8 years 6 months as per MCA records. was documented.
The CIN of Hetas Pharmaceuticals Private Limited is U74999DL2017PTC318145.
Hetas Pharmaceuticals Private Limited is headquartered at K-1/114,First Floor, Cr Park, New Delhi, Delhi, 110019.
Hetas Pharmaceuticals Private Limited was incorporated on 25 May 2017.
The current directors of Hetas Pharmaceuticals Private Limited are
The primary industry of Hetas Pharmaceuticals Private Limited is Business Services.
Hetas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hetas Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Hetas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX